Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash & Equivalents: 2009-2011

Historic Cash & Equivalents for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $186.3 million.

  • Lexicon Pharmaceuticals' Cash & Equivalents fell 31.98% to $20.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $20.8 million, marking a year-over-year decrease of 31.98%. This contributed to the annual value of $186.3 million for FY2011, which is 294.66% up from last year.
  • According to the latest figures from FY2011, Lexicon Pharmaceuticals' Cash & Equivalents is $186.3 million, which was up 294.66% from $47.2 million recorded in FY2010.
  • Lexicon Pharmaceuticals' Cash & Equivalents' 5-year high stood at $186.3 million during FY2011, with a 5-year trough of $47.2 million in FY2010.
  • In the last 3 years, Lexicon Pharmaceuticals' Cash & Equivalents had a median value of $100.6 million in 2009 and averaged $111.4 million.
  • In the last 5 years, Lexicon Pharmaceuticals' Cash & Equivalents tumbled by 53.05% in 2010 and then skyrocketed by 294.66% in 2011.
  • Yearly analysis of 3 years shows Lexicon Pharmaceuticals' Cash & Equivalents stood at $100.6 million in 2009, then crashed by 53.05% to $47.2 million in 2010, then soared by 294.66% to $186.3 million in 2011.